切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2017, Vol. 06 ›› Issue (04) : 280 -284. doi: 10.3877/cma.j.issn.2095-3232.2017.04.010

所属专题: 文献

临床研究

射频消融与手术切除治疗早期肝细胞癌疗效比较Meta分析
崔瑞文1, 朱曙光1, 范磊2, 郑世杨3, 李华1,()   
  1. 1. 510630 广州,中山大学附属第三医院肝脏外科
    2. 510630 广州,中山大学附属第三医院脊柱外科
    3. 510630 广州,中山大学附属第三医院甲乳外科
  • 收稿日期:2017-03-20 出版日期:2017-08-10
  • 通信作者: 李华
  • 基金资助:
    国家自然科学基金(81172038); 广东省自然科学基金(2014A020212484)

Comparison of clinical efficacy between radiofrequency ablation and surgical resection for early hepatocellular carcinoma: a Meta-analysis

Ruiwen Cui1, Shuguang Zhu1, Lei Fan2, Shiyang Zheng3, Hua Li1,()   

  1. 1. Department of Liver Surgery, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China
    2. Department of Spine Surgery, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China
    3. Department of Breast and Thyroid Surgery, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China
  • Received:2017-03-20 Published:2017-08-10
  • Corresponding author: Hua Li
  • About author:
    Corresponding author:Li Hua, Email:
引用本文:

崔瑞文, 朱曙光, 范磊, 郑世杨, 李华. 射频消融与手术切除治疗早期肝细胞癌疗效比较Meta分析[J/OL]. 中华肝脏外科手术学电子杂志, 2017, 06(04): 280-284.

Ruiwen Cui, Shuguang Zhu, Lei Fan, Shiyang Zheng, Hua Li. Comparison of clinical efficacy between radiofrequency ablation and surgical resection for early hepatocellular carcinoma: a Meta-analysis[J/OL]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2017, 06(04): 280-284.

目的

比较射频消融(RFA)和手术切除(SR)治疗早期肝细胞癌(肝癌)的疗效。

方法

计算机检索2004年1月至2017年2月在PubMed、Embase、Web of science、中国知网和万方数据库公开发表的有关RFA和SR治疗早期肝癌的文献。英文检索词包括:hepatocellular carcinoma、liver cancer、hepatic carcinoma、liver neoplasms、HCC、radiofrequency ablation、ablative therapy、RFA、surgical resection、hepatectomy。中文检索词包括:肝细胞癌、肝癌、肝脏肿瘤、射频消融、手术切除。对符合米兰标准的早期肝癌患者提取生存率、并发症发生率及围手术期住院时间等数据进行Meta分析。异质性研究采用随机效应模型分析,同质性研究采用固定效应模型分析。

结果

共纳入20篇文献,其中4篇为随机对照试验研究,16篇为回顾性研究。共包括3 849例早期肝癌患者,其中1 946例行SR治疗,1 903例行RFA治疗。SR患者术后3、5年总体生存率较RFA患者明显升高(OR=1.09,1.58;P<0.05)。SR患者术后1、3、5年无瘤生存率较RFA患者明显升高(OR=1.88,2.31,2.14;P<0.05)。SR患者术后1、3、5年肿瘤复发率较RFA患者明显降低(OR=0.57,0.18,0.46;P<0.05)。SR患者术后并发症发生率较RFA患者明显升高(OR=3.84,P<0.05)。SR患者围手术期住院时间较RFA患者明显延长(WMD=7.08,P<0.05)。

结论

对于符合米兰标准的早期肝癌患者,SR长期生存及复发方面明显优于RFA,但RFA具有微创、并发症发生率低、住院时间短等优势。

Objective

To compare the clinical efficacy between radiofrequency ablation (RFA) and surgical resection (SR) for early hepatocellular carcinoma (HCC).

Methods

Open published literatures related to RFA and SR for the treatment of early HCC between January 2004 and February 2017 were searched by computer from PubMed, Embase, Web of science, CNKI and Wanfang databases. The researching keywords in Chinese and English included hepatocellular carcinoma, liver cancer, hepatic carcinoma, liver neoplasms, HCC, radiofrequency ablation, ablative therapy, RFA, surgical resection and hepatectomy. The clinical data including survival rate, incidence of complication and perioperative length of hospital stay of the early HCC patients up to the standard of Milan criteria were extracted for Meta-analysis. Heterogenous studies were analyzed using random effect model, and homogenous studies were analyzed using fixed effect model.

Results

A total of 20 literatures including 4 randomized control trials and 16 retrospective studies were included in this Meta-analysis. In total, 3 849 patients with early HCC were analyzed. Among the patients, 1 946 cases underwent SR and 1 903 underwent RFA. The postoperative 3-, 5-year overall survival rate of the SR patients was significantly higher than those of the RFA patients (OR=1.09, 1.58; P<0.05). The postoperative 1-, 3-, 5-year tumor-free survival rate of the SR patients was significantly higher than those of the RFA patients (OR=1.88, 2.31, 2.14; P<0.05). The postoperative 1-, 3-, 5-year tumor recurrence rate of the SR patients was significantly lower than those of the RFA patients (OR=0.57, 0.18, 0.46; P<0.05). The incidence of postoperative complications of the SR patients was significantly higher than that of the RFA patients (OR=3.84, P<0.05). The perioperative length of hospital stay of the SR patients was significantly higher than that of the RFA patients (WMD=7.08, P<0.05).

Conclusions

For early HCC patients up to the standard of Milan criteria, the long-term survival and recurrence of SR are significantly superior to those of RFA. Nevertheless, RFA has the advantages of minimal invasion, low incidence of postoperative complications and short length of hospital stay.

图1 手术切除与射频消融治疗早期肝癌5年总体生存率比较Meta分析森林图
图2 纳入研究的发表偏倚漏斗图
[1]
Sartorius K, Sartorius B, Aldous C, et al. Global and country underestimation of hepatocellular carcinoma (HCC) in 2012 and its implications[J]. Cancer Epidemiol, 2015, 39(3):284-290.
[2]
Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis[J]. N Engl J Med, 1996, 334(11):693-699.
[3]
张洪新.肝细胞肝癌微创综合治疗的现状与展望[J/CD].中华肝脏外科手术学电子杂志,2013,2(3):146-148.
[4]
Feng K, Yan J, Li X, et al. A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma[J]. J Hepatol, 2012, 57(4):794-802.
[5]
Huang J, Yan L, Cheng Z, et al. A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria[J]. Ann Surg, 2010, 252(6):903-912.
[6]
Chen MS, Li JQ, Zheng Y, et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma[J]. Ann Surg, 2006, 243(3):321-328.
[7]
吕明德,匡铭,梁力建,等.手术切除和经皮热消融治疗早期肝癌的随机对照临床研究[J].中华医学杂志,2006,86(12):801-805.
[8]
Desiderio J, Trastulli S, Pasquale R, et al. Could radiofrequency ablation replace liver resection for small hepatocellular carcinoma in patients with compensated cirrhosis? a 5-year follow-up[J]. Langenbecks Arch Surg, 2013, 398(1):55-62.
[9]
Wong KM, Yeh ML, Chuang SC, et al. Survival comparison between surgical resection and percutaneous radiofrequency ablation for patients in Barcelona Clinic Liver Cancer early stage hepatocellular carcinoma[J]. Indian J Gastroenterol, 2013, 32(4):253-257.
[10]
Peng ZW, Lin XJ, Zhang YJ, et al. Radiofrequency ablation versus hepatic resection for the treatment of hepatocellular carcinomas 2 cm or smaller: a retrospective comparative study[J]. Radiology, 2012, 262(3):1022-1033.
[11]
Lai EC, Tang CN. Radiofrequency ablation versus hepatic resection for hepatocellular carcinoma within the Milan criteria- a comparative study [J]. Int J Surg, 2013, 11(1):77-80.
[12]
Liu PH, Hsu CY, Hsia CY, et al. Surgical resection versus radiofrequency ablation for single hepatocellular carcinoma ≤2 cm in a propensity score model[J]. Ann Surg, 2016, 263(3):538-545.
[13]
Hong SN, Lee SY, Choi MS, et al. Comparing the outcomes of radiofrequency ablation and surgery in patients with a single small hepatocellular carcinoma and well-preserved hepatic function[J]. J Clin Gastroenterol, 2005, 39(3):247-252.
[14]
Hung HH, Chiou YY, Hsia CY, et al. Survival rates are comparable after radiofrequency ablation or surgery in patients with small hepatocellular carcinomas[J]. Clin Gastroenterol Hepatol, 2011, 9(1):79-86.
[15]
Wang JH, Wang CC, Hung CH, et al. Survival comparison between surgical resection and radiofrequency ablation for patients in BCLC very early/early stage hepatocellular carcinoma[J]. J Hepatol, 2012, 56(2):412-418.
[16]
Kang TW, Kim JM, Rhim H, et al. Small hepatocellular carcinoma: radiofrequency ablation versus nonanatomic resection-propensity score analyses of long-term outcomes[J]. Radiology, 2015, 275(3):908-919.
[17]
Hocquelet A, Balageas P, Laurent C, et al. Radiofrequency ablation versus surgical resection for hepatocellular carcinoma within the Milan criteria: a study of 281 Western patients[J]. Int J Hyperthermia, 2015, 31(7):749-757.
[18]
Gory I, Fink M, Bell S, et al. Radiofrequency ablation versus resection for the treatment of early stage hepatocellular carcinoma: a multicenter Australian study[J]. Scand J Gastroenterol, 2015, 50(5):567-576.
[19]
Bu X, Ge Z, Ma J, et al. Long-term efficacy of radiofrequency ablation compared to surgical resection for the treatment of small hepatocellular carcinoma[J]. J BUON, 2015, 20(2):548-554.
[20]
Pompili M, Saviano A, de Matthaeis N, et al. Long-term effectiveness of resection and radiofrequency ablation for single hepatocellular carcinoma ≤3 cm. results of a multicenter Italian survey[J]. J Hepatol, 2013, 59(1):89-97.
[21]
Park EK, Kim HJ, Kim CY, et al. A comparison between surgical resection and radiofrequency ablation in the treatment of hepatocellular carcinoma[J]. Ann Surg Treat Res, 2014, 87(2):72-80.
[22]
Guan TP, Fang CH, Yang J, et al. A comparison between three-dimensional visualization guided hepatectomy and ultrasonography guided radiofrequency ablation in the treatment of small hepatocellular carcinoma within the milan criteria[J]. Biomed Res Int, 2016:8931732.
[23]
Vivarelli M, Guglielmi A, Ruzzenente A, et al. Surgical resection versus percutaneous radiofrequency ablation in the treatment of hepatocellular carcinoma on cirrhotic liver[J]. Ann Surg, 2004, 240(1):102-107.
[24]
Wakai T, Shirai Y, Suda T, et al. Long-term outcomes of hepatectomy vs percutaneous ablation for treatment of hepatocellular carcinoma < or =4 cm[J]. World J Gastroenterol, 2006, 12(4):546-552.
[25]
何坤,胡泽民,余元龙,等.精准肝切除在原发性肝癌中的应用[J/CD].中华肝脏外科手术学电子杂志,2016,5(2):81-85.
[1] 钟锴, 蒋铁民, 张瑞青, 吐尔干艾力·阿吉, 邵英梅, 郭强. 加速康复外科在肝囊型棘球蚴病肝切除术中的应用分析[J/OL]. 中华普通外科学文献(电子版), 2024, 18(06): 425-429.
[2] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[3] 常小伟, 蔡瑜, 赵志勇, 张伟. 高强度聚焦超声消融术联合肝动脉化疗栓塞术治疗原发性肝细胞癌的效果及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 56-59.
[4] 冯旺, 马振中, 汤林花. CT扫描三维重建在肝内胆管细胞癌腹腔镜肝切除术中的临床研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 104-107.
[5] 赖全友, 高远, 汪建林, 屈士斌, 魏丹, 彭伟. 三维重建技术结合腹腔镜精准肝切除术对肝癌患者术后CD4+、CD8+及免疫球蛋白水平的影响[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 651-654.
[6] 唐梅, 周丽, 牛岑月, 周小童, 王倩. ICG荧光导航的腹腔镜肝切除术临床意义[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 655-658.
[7] 公宇, 廖媛, 尚梅. 肝细胞癌TACE术后复发影响因素及预测模型建立[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 818-824.
[8] 李一帆, 朱帝文, 任伟新, 鲍应军, 顾俊鹏, 张海潇, 曹耿飞, 阿斯哈尔·哈斯木, 纪卫政. 血GP73水平在原发性肝癌TACE疗效评价中的作用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 825-830.
[9] 刘敏思, 李荣, 李媚. 基于GGT与Plt比值的模型在HBV相关肝细胞癌诊断中的作用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 831-835.
[10] 焦振东, 惠鹏, 金上博. 三维可视化结合ICG显像技术在腹腔镜肝切除术治疗复发性肝癌中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 859-864.
[11] 陈晓鹏, 王佳妮, 练庆海, 杨九妹. 肝细胞癌VOPP1表达及其与预后的关系[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 876-882.
[12] 袁雨涵, 杨盛力. 体液和组织蛋白质组学分析在肝癌早期分子诊断中的研究进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 883-888.
[13] 吴警, 吐尔洪江·吐逊, 温浩. 肝切除术前肝功能评估新进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 889-893.
[14] 吴雪云, 胡小军, 范应方. 肝切除术中剩余肝再生能力的评估与预测[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 894-897.
[15] 杭轶, 杨小勇, 李文美, 薛磊. 可控性低中心静脉压技术在肝切除术中应用的最适中心静脉压[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 813-817.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?